---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-041237"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2023-04-04T23:59:59+00:00"
generated_at: "2026-06-17T06:26:46.751887+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Annovis Bio terminates $50M ATM equity facility after selling 704K shares for $7.66M

## Summary
- Terminated ATM Sales Agreement with BofA Securities and ThinkEquity, effective April 9, 2023.
- Prior to termination, sold 704,000 shares at $10.88/share for gross proceeds of $7,659,520.
- No termination penalties incurred; no further shares will be offered under the agreement.
- Original agreement allowed up to $50M in common stock sales; only ~15% utilized.

## SEC filing metadata
- accession: 0001104659-23-041237
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2023-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000110465923041237/0001104659-23-041237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000110465923041237/tm2311180d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-041237
- JSON: https://secwatch.observer/filing/0001104659-23-041237.json
- Plain text: https://secwatch.observer/filing/0001104659-23-041237.txt

## Key facts
- Material Agreements
  Annovis Bio, Inc. terminated ATM Equity Offering Sales Agreement with BofA Securities, Inc. and ThinkEquity LLC valued at up to $50,000,000 (effective 2023-04-09).
  - Action: termination
  - Agreement: atm program
  - Counterparty: BofA Securities, Inc. and ThinkEquity LLC
  - Value: up to $50,000,000
  - Effective: 2023-04-09
  source text: On April 4, 2023, the Company delivered written notice to BofA and ThinkEquity to terminate the Sales Agreement, effective April 9, 2023, pursuant to Section 9(a) of the Sales Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1477845/000110465923041237/0001104659-23-041237-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.